1,471
Participants
Start Date
May 15, 2015
Primary Completion Date
July 7, 2016
Study Completion Date
July 7, 2016
Levonorgestrel (BAY98-7196)
Levonorgestrel 40 µg/d intravaginal ring (treatment for 365 days, 28 days wearing period for each ring)
Port Jefferson
Johnson City
Williamsville
Rochester
Pittsburgh
Pittsburgh
Philadelphia
Lutherville
Richmond
Virginia Beach
Winston-Salem
Greensboro
Cary
Raleigh
Raleigh
Durham
Salisbury
Charlotte
Wilmington
New Bern
Columbia
Mt. Pleasant
Summerville
Myrtle Beach
Roswell
Atlanta
Jacksonville
Oviedo
Miami Beach
North Miami
Miami
Wellington
Jupiter
Lake Worth
St. Petersburg
Clearwater
Leesburg
Mobile
Columbus
Cleveland
Chicago
Champaign
Kansas City
Shawnee Mission
Wichita
Lincoln
Little Rock
Houston
Houston
San Antonio
Corpus Christi
Denver
Denver
Idaho Falls
Draper
Pleasant Grove
Salt Lake City
Phoenix
Mesa
Chandler
Tucson
Albuquerque
Las Vegas
Las Vegas
Las Vegas
La Mesa
San Diego
San Diego
San Diego
Sacramento
Sacramento
Seattle
Spokane
New London
Baltimore
Lawrenceville
New Brunswick
Cincinnati
Jackson
Funabashi
Yotsukaidō
Aki-gun
Sapporo
Sapporo
Kurashiki
Chuo-ku
Hachiōji
Nakano-ku
Nishitōkyō
Ōta-ku
Setagaya-ku
Shinjuku
Toshima-ku
Fukui
Fukui
Fukui
Fukuoka
Osaka
Osaka
Osaka
Lead Sponsor
Bayer
INDUSTRY